Evaluation of Inactivation Methods for Rift Valley Fever Virus in Mouse Microglia
Rift Valley fever phlebovirus (RVFV) is a highly pathogenic mosquito-borne virus with bioweapon potential due to its ability to be spread by aerosol transmission. Neurological symptoms are among the worst outcomes of infection, and understanding of pathogenesis mechanisms within the brain is limited...
Main Authors: | Margarita V. Rangel, Feliza A. Bourguet, Carolyn I. Hall, Dina R. Weilhammer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/13/2/159 |
Similar Items
-
Novel approaches to develop Rift Valley fever vaccines
by: Sabarish V. Indran, et al.
Published: (2012-10-01) -
Rift Valley Fever, Mayotte, 2007–2008
by: Daouda Sissoko, et al.
Published: (2009-04-01) -
Rift Valley Fever Reemergence after 7 Years of Quiescence, South Africa, May 2018
by: Petrus Jansen van Vuren, et al.
Published: (2019-02-01) -
Replication of Rift Valley Fever Virus in Amphibian and Reptile-Derived Cell Lines
by: Melanie Rissmann, et al.
Published: (2021-05-01) -
High seroprevalence of Rift Valley fever phlebovirus in domestic ruminants and African Buffaloes in Mozambique shows need for intensified surveillance
by: Belisário Moiane, et al.
Published: (2017-01-01)